To study the composition and spatial patterning of immune cells within tumor tissues in the absence or presence of immunotherapy, we first utilized the MC38 murine colorectal carcinoma model, which has been previously shown to exhibit moderate CD8 T cell responses to checkpoint blockade therapy. This evidence concerns the gene CD8A and colorectal carcinoma.